Compounds > quinoxalines
Page last updated: 2024-08-17

quinoxalines and n(6)-cyclohexyladenosine

quinoxalines has been researched along with n(6)-cyclohexyladenosine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (60.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Browne, RG; Howard, HR; Koe, BK; Lebel, LA; Sarges, R; Seymour, PA1
Fredholm, BB; Hu, PS1
Fowler, JC; Gervitz, L; Partridge, LD1
Catarzi, D; Colotta, V; Filacchioni, G; Lucacchini, A; Martini, C; Trincavelli, L; Varano, F2

Other Studies

5 other study(ies) available for quinoxalines and n(6)-cyclohexyladenosine

ArticleYear
4-Amino[1,2,4]triazolo[4,3-a]quinoxalines. A novel class of potent adenosine receptor antagonists and potential rapid-onset antidepressants.
    Journal of medicinal chemistry, 1990, Volume: 33, Issue:8

    Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Antidepressive Agents; Behavior, Animal; Caffeine; Cats; Cell Membrane; Cerebral Cortex; Chemical Phenomena; Chemistry; Corpus Striatum; Male; Molecular Structure; Motor Activity; Purinergic Antagonists; Quinoxalines; Rats; Receptors, Purinergic; Sleep; Structure-Activity Relationship; Triazoles

1990
Effect of an intracellular calcium chelator on the regulation of electrically evoked [3H]-noradrenaline release from rat hippocampal slices.
    British journal of pharmacology, 1993, Volume: 108, Issue:1

    Topics: Adenosine; Adrenergic alpha-Agonists; Animals; Brimonidine Tartrate; Calcium; Calcium Channel Blockers; Chelating Agents; Dioxanes; Egtazic Acid; Electric Stimulation; Hippocampus; Idazoxan; In Vitro Techniques; Male; Norepinephrine; omega-Conotoxins; Peptides, Cyclic; Quinoxalines; Rats; Rats, Sprague-Dawley

1993
Hydroxylamine blocks pre- but not postsynaptic adenosine A(1) receptor-mediated actions in rat hippocampus.
    Brain research, 1999, Aug-07, Volume: 837, Issue:1-2

    Topics: Adenosine; Animals; Calcium; Evoked Potentials; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Hippocampus; Hydroxylamine; In Vitro Techniques; Magnesium; Male; Nitric Oxide Donors; Presynaptic Terminals; Purinergic P1 Receptor Antagonists; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Synapses

1999
Synthesis and structure-activity relationships of 4-cycloalkylamino-1, 2, 4-triazolo[4, 3-a]quinoxalin-1- one derivatives as A1 and A3 adenosine receptor antagonists.
    Archiv der Pharmazie, 2004, Volume: 337, Issue:1

    Topics: Adenosine; Alkanes; Animals; Binding Sites; Binding, Competitive; Cattle; Cerebral Cortex; CHO Cells; Cricetinae; Humans; Iodine Isotopes; Membranes; Neostriatum; Phenethylamines; Purinergic Antagonists; Quantitative Structure-Activity Relationship; Quinoxalines; Receptors, Purinergic; Triazoles; Tritium

2004
1,2,4-Triazolo[1,5-a]quinoxaline derivatives: synthesis and biological evaluation as adenosine receptor antagonists.
    Farmaco (Societa chimica italiana : 1989), 2004, Volume: 59, Issue:2

    Topics: Adenosine; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Adenosine A3 Receptor Antagonists; Animals; Binding, Competitive; Cattle; Cerebral Cortex; CHO Cells; Cricetinae; Humans; In Vitro Techniques; Indicators and Reagents; Kinetics; Magnetic Resonance Spectroscopy; Neostriatum; Purinergic P1 Receptor Antagonists; Quinoxalines; Spectrophotometry, Infrared; Structure-Activity Relationship; Triazoles

2004